MedinCell SA Sustainability Reports
MedinCell S.A. is a clinical- and commercial-stage biopharmaceutical company that develops long-acting injectable treatments. The company utilizes its proprietary BEPO technology platform to provide controlled, sustained drug delivery for various therapeutic areas.
Sector: Manufacturing
Country: France
Exchange: Euronext Paris
LEI: 969500R79U6PXCL2FF46
FIGI: BBG00J2HMMW0
14 reports from 2019 to 2026
